Iron Home > Curriculum > Curriculum 4 > Series of 10 Reports from the 51st American Society of Hematology (ASH) Ann...
Series of 10 Reports from the 51st American Society of Hematology (ASH) Annual Meeting and Exposition in New Orleans, Louisiana 2009
Chronic medical conditions that cause anaemia necessitate frequent transfusions of packed red blood cells. Iron overload is a serious clinical consequence of these transfusions, and clinicians treating these patients are responsible for managing the iron burden. Several iron chelation agents are approved throughout the world for treating iron overload, but further research is needed in a number of important areas so that clinicians may improve patient outcomes. Topics of interest include the most efficacious regimens for reducing the iron burden in the heart along with the liver, the optimal regimens for patients with different underlying causes of anaemia, long-term efficacy and safety of therapy overall, prognostic indicators for the efficacy of iron chelation therapy, treatment adherence, patient satisfaction with treatment, and health-related quality of life.
Target AudienceThis activity is designed for haematologists, medical oncologists, haematology-oncology specialists, and other healthcare professionals involved in the screening, evaluation, treatment, and management of adults and children with iron overload, resulting from the spectrum of chronic iron overload diseases.
- Evaluate recent clinical trial data on the safety and efficacy of available iron chelators as single agents and in combination regimens in order to improve outcomes, compliance, and patient satisfaction in patients with beta thalassaemia.
- Apply recent clinical trial data on deferasirox in determining the most effective treatment for patients with myelodysplastic syndrome and hereditary haemochromatosis.
- Incorporate recent clinical trial results with desferrioxamine and deferasirox in determining treatment that facilitates compliance in patients with sickle cell disease.
The Curriculum in Iron Metabolism & Related Disorders is supported by an educational grant from
1 avenue Claude Vellefaux.
75475 Paris Cedex 10, France
All Rights Reserved
Copyright ESH 2020